Role of the general practitioner during the active breast cancer treatment phase: an analysis of health care use

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

(2010) Myrthe P. P. van Herk-Sukel et al.   BREAST CANCER RESEARCH AND TREATMENT

Determining the date of diagnosis – is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care

(2009) A Rosemary Tate et al.   BMC Medical Research Methodology

Predictors of Toxicity and Toxicity Profile of Adjuvant Chemotherapy in Elderly Breast Cancer Patients

(2009) Praveen Garg et al.   Breast Journal

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

(2009) Peyman Hadji   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical Mistrust

(2009) Nina A. Bickell et al.   JOURNAL OF CLINICAL ONCOLOGY

Identifying patients with a cancer diagnosis using general practice medical records and Cancer Registry data

(2008) S. W Pascoe et al.   FAMILY PRACTICE

Tailored Chemotherapy Information Faxed to General Practitioners Improves Confidence in Managing Adverse Effects and Satisfaction With Shared Care: Results From a Randomized Controlled Trial

(2008) Michael Jefford et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary Care Physicians and Oncologists Are Players on the Same Team

(2008) Eva Grunfeld   JOURNAL OF CLINICAL ONCOLOGY

Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007

(2008) Ali Montazeri   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY